# Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose)

> **NCT05789251** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de la Réunion** · enrollment: 60 (estimated)

## Conditions studied

- Lipodystrophy

## Interventions

- **DIAGNOSTIC_TEST:** Standardized breakfast

## Key facts

- **NCT ID:** NCT05789251
- **Lead sponsor:** Centre Hospitalier Universitaire de la Réunion
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-19
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789251, "Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05789251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*